Evidence map›Paper›PMID 35126794›Full record

ArticleDisease markers2022

Prognostic Value and Immune-Infiltration Pattern of

Zhujuan Yang, Xiaoqing Shen, Shanhui Luo, Yi Li

Open access · hybridAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Disease markers, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
0.4field-weighted citation impact, top 40% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 2 citations in OpenAlex.

  1. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 2 institutions in 1 country.

Zhujuan YangDepartment of Gynecology, The Second Affiliated Hospital of Soochow University, Suzhou, China.
Xiaoqing ShenDepartment of Gynecology, The Second Affiliated Hospital of Soochow University, Suzhou, China.
Shanhui LuoDepartment of Gynecology, The Second Affiliated Hospital of Soochow University, Suzhou, China.
Yi LiDepartment of Gynecology, The Affiliated Jiangsu Shengze Hospital of Nanjing Medical University & Jiangsu Shengze Hospital, Suzhou, China.ORCID https://orcid.org/0000-0001-5866-5783
Soochow University · CNJiangsu Shengze Hospital · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundWith the development of sequencing technology, an increasing number of biomarkers has been identified in endometrial carcinoma (EC). However, there have been few comprehensive analyses of the

methodsBased on raw data in public databases, the

resultsIn the pan-cancer analysis,

conclusionWe provided robust evidences that

Indexed as

Biomarkers, TumorEndometrial NeoplasmsFemaleHumansKinesinsPredictive Value of TestsPrognosisBiomarkers, TumorKIF4A protein, humanKinesins

Identifiers

PMID35126794
PMCPMC8814714
OpenAlexW4206708201

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.